Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Study Shows New Challenges for MS Patients

January 13, 2015 9:51 am | by University of Aberdeen | News | Comments

This new study paves the way for future interventions to include ways to improve emotion regulation. Read more...                         


MRI Could Predict Alzheimer's Disease

January 13, 2015 9:15 am | by University of Queensland | News | Comments

Scientists have discovered that magnetic resonance imaging (MRI) could be used to predict the risk of Alzheimer’s disease. Read more...                     


Researchers Discover Personalized Therapy for Cardiovascular Disease

January 13, 2015 9:09 am | by Montreal Heart Institute | News | Comments

This is a world-first discovery regarding a new medication called dalcetrapid. Read more...                            


China Sending Large Ebola Relief Team to West Africa

January 13, 2015 8:56 am | by Associated Press | News | Comments

China is ramping up its assistance in the fight against Ebola by dispatching an additional 232 army medical workers to West Africa. Read more...                    


In the News: Open Access Journals

January 13, 2015 8:55 am | by Drug Discovery & Development Staff | Articles | Comments

A number of open access journals have made the news recently. The preprint open access archive,, run by Cornell University, is often used by scientists, from physicists to quantitative biologists, to get their ideas out there quickly and stake out their intellectual ground, before they enter the slow process of peer review. Read more...


FDA Clears Milestone Pharmaceutical's PSVT Drug for Phase 2 Study

January 13, 2015 8:53 am | News | Comments

The drug is for the treatment of acute episodes of Paroxysmal Supraventricular Tachycardia (PSVT). The trial is expected to begin patient enrollment in early 2015. Read more...              


19 Measles Cases Reported with Ties to Disney Theme Parks

January 12, 2015 1:07 pm | by Amy Taxin - Associated Press | News | Comments

Nineteen people from three states who visited Disney theme parks in California last month have now fallen ill with measles. Read more...                     


Celator Announces Promising Phase 2 Data for AML Drug

January 12, 2015 12:58 pm | News | Comments

Celator Pharmaceuticals published this data earlier today. Read more...                                


Targeting Brain Cancer Cells with a Wound-Healing Drug

January 12, 2015 12:47 pm | by Ashley WennersHerron - Virginia Tech | News | Comments

Scientists are planning to create a virus capable of destroying brain cancer. Read more...                             


Scientists Find Possible Target for Treating Brain Inflammation

January 12, 2015 12:34 pm | by The Scripps Research Institute | News | Comments

Scientists identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Read more...                         


Roche, Foundation Medicine Team Up for Cancer Treatment Research

January 12, 2015 12:25 pm | News | Comments

The emerging field of molecular information and genomic analysis will play an increasingly important role for future medicines and diagnostic solutions. Read more...                


Amerisourcebergen Expands into Animal Health with $2.5B Deal

January 12, 2015 12:19 pm | by Associated Press | News | Comments

Pharmaceutical distributor AmerisourceBergen will stretch its reach into veterinary medicine by spending about $2.5 billion to acquire MWI Veterinary Supply. Read more...               


UroSens Gets $2M to Commercialize Bladder, Prostate Cancer Test

January 12, 2015 11:21 am | by UroSens | News | Comments

UroSens Ltd, a diagnostic company developing novel, non-invasive urine tests for the detection of prostate and bladder cancer, has announced it has received £2 million ($3.02 million) investment. Read more...                                            


Clementia Pharmaceuticals: New Site for FOP Trial

January 12, 2015 11:15 am | News | Comments

Clementia Pharmaceuticals, Inc. announced the opening of a new site in Paris, France for the Phase 2 clinical trial of palovarotene, the company's lead product candidate for the treatment of fibrodysplasia ossificans progressiva (FOP).  Read more...      


New Hope to Prevent Chemo Side Effects

January 12, 2015 11:11 am | by University of Adelaide | News | Comments

Research at the University of Adelaide is pointing towards a possible prevention of severe gut problems for patients undergoing chemotherapy for cancer. Read more...                             



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.